Tuesday, November 24, 2009, 5:18AM AEST - The Australian Stockmarket opens in 4 hours and 42 minutes.
To create a watchlist or portfolio of shares, Register

Progenics Pharmaceuticals Inc. (PGNX)

5:03AM AEST: 4.09 USD  Up 0.02 (0.49%)  
 MORE ON PGNX 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Progenics Pharmaceuticals Inc. (NGM:PGNX) Delayed quote dataEdit
Last Trade:4.09 USD
Trade Time: 5:03AM AEST
Change:Up 0.02 (0.49%)
Prev Close:4.07
Open:4.10
Bid:4.09 x 200
Ask:4.10 x 200
1y Target Est:6.50
Day's Range:4.04 - 4.16
52wk Range:3.53 - 10.81
Volume:212,509
Avg Vol (3m):146,618
Market Cap:129.50M
P/E (ttm):N/A
EPS (ttm):-1.47
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add PGNX to Portfolio   Download Data

 HEADLINES 
A Possible New Indication for Progenix's Relistor Could Revive Its Fortunes
at Seeking Alpha (Fri, Nov 20)
Pain drug morphine may accelerate cancer growth
at Reuters (Thu, Nov 19)
4-Star Stocks on the Upswing
at Motley Fool (Thu, Nov 19)
Progenics: Are the Prospects That Bad?
at Seeking Alpha (Tue, Nov 17)
PROGENICS PHARMACEUTICALS INC Financials
EDGAR Online Financials (Sat, Nov 14)
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition
EDGAR Online (Tue, Nov 10)
CORRECTING and REPLACING Progenics Announces Third Quarter 2009 Financial Results
Business Wire (Tue, Nov 10)
BioMed Realty Trust Extends Lease at Landmark With Progenics Pharmaceuticals
PR Newswire (Fri, Oct 30)
PROGENICS PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement
EDGAR Online (Sat, Oct 17)
Biotech Stock Mailbag: Oncothyreon
at TheStreet.com (Fri, Oct 16)
This Partnership Will Go No Further
at Motley Fool (Fri, Oct 16)
Progenics Pharm downgraded by Needham
Briefing.com (Thu, Oct 15)
More Headlines for PGNX...

 ANALYST 
EPS Est (next year) (Dec-09) :-1.12
EPS Est (in 2 years) (Dec-10) :-1.43
Avg Rec (current)*:2.6
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Progenics Pharmaceuticals, Inc., a biopharmaceutical company, engages in the development and commercialization of therapeutic products to treat the unmet medical needs of patients with debilitating conditions and life-threatening diseases in the U...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
Latest News7 Indices